ESGYX
Price
$20.74
Change
+$0.09 (+0.44%)
Updated
Jan 22 closing price
Net Assets
996.87M
NPFCX
Price
$60.26
Change
+$0.31 (+0.52%)
Updated
Jan 22 closing price
Net Assets
146.92B
Ad is loading...

ESGYX vs NPFCX

Header iconESGYX vs NPFCX Comparison
Open Charts ESGYX vs NPFCXBanner chart's image
Mirova Global Sustainable Equity Y
Price$20.74
Change+$0.09 (+0.44%)
VolumeN/A
Net Assets996.87M
American Funds New Perspective C
Price$60.26
Change+$0.31 (+0.52%)
VolumeN/A
Net Assets146.92B
ESGYX vs NPFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ESGYX vs. NPFCX commentary
Jan 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ESGYX is a Buy and NPFCX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
NPFCX has more cash in the bank: 147B vs. ESGYX (997M). ESGYX pays higher dividends than NPFCX: ESGYX (0.55) vs NPFCX (0.20). ESGYX was incepted earlier than NPFCX: ESGYX (9 years) vs NPFCX (24 years). ESGYX is a more actively managed with annual turnover of: 23.00 vs. NPFCX (17.00). NPFCX has a lower initial minimum investment than ESGYX: NPFCX (250) vs ESGYX (100000). NPFCX annual gain was more profitable for investors over the last year : 15.26 vs. ESGYX (14.06). ESGYX return over 5 years is better than : 36.42 vs. NPFCX (30.44).
ESGYXNPFCXESGYX / NPFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years24 years-
Gain YTD3.2874.07681%
Front LoadN/AN/A-
Min. Initial Investment10000025040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets997M147B1%
Annual Yield % from dividends0.550.20277%
Returns for 1 year14.0615.2692%
Returns for 3 years11.715.84201%
Returns for 5 years36.4230.44120%
Returns for 10 yearsN/A69.40-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HTCR1.690.07
+4.32%
Heartcore Enterprises
PEBO32.200.85
+2.71%
Peoples Bancorp
CLVT5.440.08
+1.49%
Clarivate Plc
CRDF3.540.02
+0.57%
Cardiff Oncology
CQP60.51-2.28
-3.63%
Cheniere Energy Partners LP